Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1157517.RAOQ2fxbx9h7vxlUVnOtKiLhgcCmljnUfmhYYKVTDkmJ8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1157517.RAOQ2fxbx9h7vxlUVnOtKiLhgcCmljnUfmhYYKVTDkmJ8130_assertion type Assertion NP1157517.RAOQ2fxbx9h7vxlUVnOtKiLhgcCmljnUfmhYYKVTDkmJ8130_head.
- NP1157517.RAOQ2fxbx9h7vxlUVnOtKiLhgcCmljnUfmhYYKVTDkmJ8130_assertion description "[Four (14%) of the ICC cases featured novel gene fusions involving the tyrosine kinases FGFR2 and NTRK1 (FGFR2-KIAA1598, FGFR2-BICC1, FGFR2-TACC3, and RABGAP1L-NTRK1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157517.RAOQ2fxbx9h7vxlUVnOtKiLhgcCmljnUfmhYYKVTDkmJ8130_provenance.
- NP1157517.RAOQ2fxbx9h7vxlUVnOtKiLhgcCmljnUfmhYYKVTDkmJ8130_assertion evidence source_evidence_literature NP1157517.RAOQ2fxbx9h7vxlUVnOtKiLhgcCmljnUfmhYYKVTDkmJ8130_provenance.
- NP1157517.RAOQ2fxbx9h7vxlUVnOtKiLhgcCmljnUfmhYYKVTDkmJ8130_assertion SIO_000772 24563076 NP1157517.RAOQ2fxbx9h7vxlUVnOtKiLhgcCmljnUfmhYYKVTDkmJ8130_provenance.
- NP1157517.RAOQ2fxbx9h7vxlUVnOtKiLhgcCmljnUfmhYYKVTDkmJ8130_assertion wasDerivedFrom befree-2016 NP1157517.RAOQ2fxbx9h7vxlUVnOtKiLhgcCmljnUfmhYYKVTDkmJ8130_provenance.
- NP1157517.RAOQ2fxbx9h7vxlUVnOtKiLhgcCmljnUfmhYYKVTDkmJ8130_assertion wasGeneratedBy ECO_0000203 NP1157517.RAOQ2fxbx9h7vxlUVnOtKiLhgcCmljnUfmhYYKVTDkmJ8130_provenance.